DI (FH) Markus Roucka

Markus started his career in the biotechnical laboratories of Biomin GmbH, Austria as Lab technician in the R&D department. He was responsible for manufacturing and QC processes of the microbial products. After almost 5 years he attended the University of Applied Science to study “Medical and Pharmaceutical Biotechnology” at the IMC Krems, Austria. For his Master thesis Markus went to The Netherlands and studied the effect of the TRIAL-ligand in combination with Bortezomib on NSCLC. Afterwards changed from green to the red biotechnology and continued his career at VelaLabs in 2008 as Senior technician in the QC department, responsible for qualification and validation of assays for large molecules. Follwed by 8 years Head of Laboratory thereby installing projects and QC processes and became Chief Operating Officer (COO) for two years. After the foundation of a Business Development Group within VelaLabs and increased further business, he also became Managing Director of VelaLabs in Vienna between 2019-2023 thereby managing up to 95 employees. Stepping out as Managing director led to the position in the Tentamus Group as Head Business Development responsible for further strategic decisions within the Tentamus Pharma Group. After almost 18 years with VelaLabs/Tentamus he moved on to Biofidus AG  in Germany as Senior VP for Business Development.